Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients

NCT06633003 is registered in ClinicalTrials.gov with ALPS Biotech CO. LTD as lead sponsor.

NCT NCT06633003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06633003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients
Lead sponsor
ALPS Biotech CO. LTD
Phase
Not applicable
Overall status
Recruiting
Start date
September 16, 2024
Completion date
August 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinocerebellar ataxia